Donepezil vs Nivolumab

## Donepezil vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Donepezil** and **Nivolumab**.

## Mechanism of Action

**Donepezil**: Reversible acetylcholinesterase inhibitor.

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Donepezil — 70 hours; Nivolumab — 27 days.

## Chemical Properties

**Molecular Formula**: Donepezil — C24H29NO3; Nivolumab — N/A.

**Molecular Weight**: Donepezil — 379.4920 g/mol; Nivolumab — N/A.

**Type**: Donepezil — Small molecule; Nivolumab — Antibody.